173 related articles for article (PubMed ID: 35116947)
1. DNA hypermethylation of
Liu X; Bi H; Ge A; Xia T; Fu J; Liu Y; Sun H; Li D; Zhao Y
Transl Cancer Res; 2019 Sep; 8(5):1985-1996. PubMed ID: 35116947
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients.
Liu X; Fu J; Bi H; Ge A; Xia T; Liu Y; Sun H; Li D; Zhao Y
BMC Cancer; 2019 Dec; 19(1):1212. PubMed ID: 31830937
[TBL] [Abstract][Full Text] [Related]
3. TFAP2E hypermethylation was associated with survival advantage in patients with colorectal cancer.
Zhang ZM; Wang Y; Huang R; Liu YP; Li X; Hu FL; Zhu L; Wang F; Cui BB; Dong XS; Zhao YS
J Cancer Res Clin Oncol; 2014 Dec; 140(12):2119-27. PubMed ID: 24996990
[TBL] [Abstract][Full Text] [Related]
4. Mapping of DNA Hypermethylation and Hypomethylation induced by Folate Deficiency in Sporadic Colorectal Cancer and Clinical Implication Analysis of Hypermethylation Pattern in CBS Promoter.
Zhang Z; He Y; Tu X; Huang S; Chen Z; Wang L; Song J
Clin Lab; 2017 Apr; 63(4):733-748. PubMed ID: 28397458
[TBL] [Abstract][Full Text] [Related]
5. PBX3 hypermethylation in peripheral blood leukocytes predicts better prognosis in colorectal cancer: A propensity score analysis.
Sun H; Huang H; Li D; Zhang L; Zhang Y; Xu J; Liu Y; Liu Y; Zhao Y
Cancer Med; 2019 Jul; 8(8):4001-4011. PubMed ID: 31140752
[TBL] [Abstract][Full Text] [Related]
6. Differential DNA methylation analysis of
Su JQ; Lai PY; Hu PH; Hu JM; Chang PK; Chen CY; Wu JJ; Lin YJ; Sun CA; Yang T; Hsu CH; Lin HC; Chou YC
World J Gastroenterol; 2022 Feb; 28(8):825-839. PubMed ID: 35317099
[TBL] [Abstract][Full Text] [Related]
7. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
[TBL] [Abstract][Full Text] [Related]
8. Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer.
Sahnane N; Magnoli F; Bernasconi B; Tibiletti MG; Romualdi C; Pedroni M; Ponz de Leon M; Magnani G; Reggiani-Bonetti L; Bertario L; Signoroni S; Capella C; Sessa F; Furlan D;
Clin Epigenetics; 2015; 7():131. PubMed ID: 26697123
[TBL] [Abstract][Full Text] [Related]
9. Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array.
Lin PC; Lin JK; Lin CH; Lin HH; Yang SH; Jiang JK; Chen WS; Chou CC; Tsai SF; Chang SC
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1419-27. PubMed ID: 25472652
[TBL] [Abstract][Full Text] [Related]
10. Genome-Wide Methylation Profiling of lncRNAs Reveals a Novel Progression-Related and Prognostic Marker for Colorectal Cancer.
Lin S; Gu S; Qian S; Liu Y; Sheng J; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Chen K; Jin M
Front Oncol; 2021; 11():782077. PubMed ID: 35127488
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor 2 hypermethylation in peripheral blood leukocytes and colorectal cancer risk and prognosis: a propensity score analysis.
Sun H; Liu Y; Zhang Y; Wang Y; Zhao Y; Liu Y
Front Oncol; 2023; 13():971435. PubMed ID: 37213278
[TBL] [Abstract][Full Text] [Related]
12. Aberrant methylated EDNRB can act as a potential diagnostic biomarker in sporadic colorectal cancer while KISS1 is controversial.
Mousavi Ardehaie R; Hashemzadeh S; Behrouz Sharif S; Ghojazadeh M; Teimoori-Toolabi L; Sakhinia E
Bioengineered; 2017 Sep; 8(5):555-564. PubMed ID: 28140749
[TBL] [Abstract][Full Text] [Related]
13. p16INK4a gene promoter hypermethylation in mucosa as a prognostic factor for patients with colorectal cancer.
Wettergren Y; Odin E; Nilsson S; Carlsson G; Gustavsson B
Mol Med; 2008; 14(7-8):412-21. PubMed ID: 18418463
[TBL] [Abstract][Full Text] [Related]
14. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis.
Tsai MH; Chen WC; Yu SL; Chen CC; Jao TM; Huang CY; Tzeng ST; Yen SJ; Yang YC
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1481-9. PubMed ID: 25968618
[TBL] [Abstract][Full Text] [Related]
15. NKX6.1 hypermethylation predicts the outcome of stage II colorectal cancer patients undergoing chemotherapy.
Chang SY; Kuo CC; Wu CC; Hsiao CW; Hu JM; Hsu CH; Chou YC; Shih YL; Lin YW
Genes Chromosomes Cancer; 2018 May; 57(5):268-277. PubMed ID: 29363224
[TBL] [Abstract][Full Text] [Related]
16. Eps15 Homology Domain-Containing Protein 3 Hypermethylation as a Prognostic and Predictive Marker for Colorectal Cancer.
Wang YH; Chang SC; Ansar M; Hung CS; Lin RK
Biomedicines; 2021 Apr; 9(5):. PubMed ID: 33922189
[TBL] [Abstract][Full Text] [Related]
17. IGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancer.
Perez-Carbonell L; Balaguer F; Toiyama Y; Egoavil C; Rojas E; Guarinos C; Andreu M; Llor X; Castells A; Jover R; Boland CR; Goel A
PLoS One; 2014; 9(8):e104285. PubMed ID: 25127039
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Values of EPDR1 Hypermethylation and Its Inhibitory Function on Tumor Invasion in Colorectal Cancer.
Chu CH; Chang SC; Wang HH; Yang SH; Lai KC; Lee TC
Cancers (Basel); 2018 Oct; 10(10):. PubMed ID: 30360391
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor gene methylation related to colorectal cancer risk.
Xia T; Sun H; Huang H; Bi H; Pu R; Zhang L; Zhang Y; Liu Y; Xu J; Onwuka JU; Liu Y; Cui B; Zhao Y
Endocr Connect; 2019 Jul; 8(7):979-987. PubMed ID: 31176300
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.
Chang SC; Liew PL; Ansar M; Lin SY; Wang SC; Hung CS; Chen JY; Jain S; Lin RK
Clin Epigenetics; 2020 May; 12(1):67. PubMed ID: 32398064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]